StockData
BDMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BDMDW

Baird Medical Investment Holdings Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026
$0.44−0.13 (-22.97%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Baird Medical Investment Holdings Ltd revenue by segment

By business segment

By product or service

RevenueFY2025FY2024FY2023FY2022% of revenueYoY
MWA devices$22.54M$37.03M$30.94M$31.28M100.0%-39.1%
MWA needles$17.21M$33.83M$26.28M$30.55M76.4%-49.1%
MWA therapeutic apparatus$5.32M$3.20M$4.66M$732.09K23.6%+66.3%
Other medical devices–$9.83K$517.53K$3.81M––

By region

RevenueFY2025FY2024FY2023FY2022% of revenueYoY
China$13.50M$36.18M$31.46M–59.9%-62.7%
Hong Kong SAR China$7.99M–––35.4%–
United States$938.75K$852.22K––4.2%+10.2%
Malaysia$106.00K–––0.5%–
Nepal$8.48K–––0.0%–

From the segment and revenue-disaggregation notes of Baird Medical Investment's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.